First-line Helicobacter pylori Eradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study
Background/Aims: The eradication rate of Helicobacter pylori with standard triple therapy as a first-line treatment has decreased to 70∼85%. Recently, concomitant therapy has been reported to overcome this decrease in eradication rate to some degree. The aim of this retrospective study was to compar...
Main Authors: | Moon Won Lee, Gwang Ha Kim, Sung Yong Han, Young Joo Park, Hye Kyung Jeon, Bong Eun Lee, Geun Am Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Yong Chan Lee
2018-06-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Subjects: | |
Online Access: | http://www.helicojournal.org/journal/view.html?doi=10.7704/kjhugr.2018.18.2.120 |
Similar Items
-
The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease
by: A M Veliev, et al.
Published: (2019-08-01) -
Addition of cranberry to proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
by: Mohammadreza Seyyedmajidi, et al.
Published: (2016-01-01) -
Concomitant or Sequential Therapy as the First-line Therapy for Eradication of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis
by: Hyun Jin Bae, et al.
Published: (2018-01-01) -
Pharmacoeconomic analysis of classic and alternative eradication therapy regimens for Helicobacter pylori
by: A. M. Veliyev, et al.
Published: (2019-05-01) -
Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
by: Hyuk Lee, et al.
Published: (2017-11-01)